HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Generics Players Dominating New OTC Launches In Germany

Executive Summary

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.

You may also be interested in...

Novartis Chief Commits To Sandoz And Its German Headquarters

Novartis has no plans to sell Sandoz, nor to move the generics division’s headquarters from its current location in Holzkirchen, Germany. Legacy German brand Hexal also remains part of the company’s plans.

Germany’s OTC Market Declines In The First Quarter Due To Mild Cold Season

A mild cold season contributed to a decline in Germany's OTC market turnover in the first quarter 2019 compared with the previous year, according to data from IQVIA. 

Hexal Seizes On Opportunity Of German Levocetirizine Switch

A prescription-to-OTC switch for levocetirizine has opened the door for generic producers such as Sandoz’ Hexal to extend their consumer healthcare allergy offerings in Germany.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts